FULLER & THALER ASSET MANAGEMENT, INC.
Position in PAHC — Phibro Animal Health Corp
CIK 1082327
SAN MATEO, CA
Position in PAHC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$380,256
New position
Shares Held
6,875
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 85%
Shared 0%
None 15%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $857,277,969 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,615,816 | $189,386,930 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
6,240,240 | $153,572,306 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,697 | $119,580,255 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
2,331,821 | $110,225,178 | |
| 5 | LQDA |
Liquidia Corp
|
1,209,604 | $96,441,726 | |
| 6 | PRGO |
PERRIGO Co plc
|
7,498,227 | $77,906,578 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,781 | $59,106,672 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
179,149 | $30,193,772 |
All Filings in PAHC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $380,256 | 6,875 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||